292 related articles for article (PubMed ID: 27527802)
1. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.
Margonis GA; Gani F; Buettner S; Amini N; Sasaki K; Andreatos N; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
HPB (Oxford); 2016 Nov; 18(11):872-878. PubMed ID: 27527802
[TBL] [Abstract][Full Text] [Related]
2. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.
Kim WS; Choi DW; You DD; Ho CY; Heo JS; Choi SH
J Gastrointest Surg; 2010 Apr; 14(4):679-87. PubMed ID: 20094817
[TBL] [Abstract][Full Text] [Related]
3. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.
Choi SB; Han HJ; Kim CY; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
Hepatogastroenterology; 2012; 59(113):36-41. PubMed ID: 22251521
[TBL] [Abstract][Full Text] [Related]
4. Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium.
Ethun CG; Postlewait LM; Le N; Pawlik TM; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick BA; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Cardona K; Maithel SK
J Surg Oncol; 2017 Jun; 115(7):805-811. PubMed ID: 28230242
[TBL] [Abstract][Full Text] [Related]
5. Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.
Beal EW; Wei L; Ethun CG; Black SM; Dillhoff M; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Pawlik TM; Scoggins C; Martin RC; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR
HPB (Oxford); 2016 Nov; 18(11):950-957. PubMed ID: 27683047
[TBL] [Abstract][Full Text] [Related]
6. Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer.
Jung W; Jang JY; Kang MJ; Chang YR; Shin YC; Chang J; Kim SW
Gut Liver; 2016 Jan; 10(1):140-6. PubMed ID: 26347513
[TBL] [Abstract][Full Text] [Related]
7. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
[TBL] [Abstract][Full Text] [Related]
8. Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.
Buettner S; Margonis GA; Kim Y; Gani F; Ethun CG; Poultsides GA; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
Ann Surg Oncol; 2016 Dec; 23(13):4401-4409. PubMed ID: 27495279
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study).
Bergquist JR; Shah HN; Habermann EB; Hernandez MC; Ivanics T; Kendrick ML; Smoot RL; Nagorney DM; Borad MJ; McWilliams RR; Truty MJ
Int J Surg; 2018 Apr; 52():171-179. PubMed ID: 29496648
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative Radiation Therapy for Gallbladder Cancer: Experience at a Single Institution.
Lee NK; Kim CY; Park YJ; Yang DS; Yoon WS; Suh SO
Hepatogastroenterology; 2014 May; 61(131):580-6. PubMed ID: 26176039
[TBL] [Abstract][Full Text] [Related]
11. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
[TBL] [Abstract][Full Text] [Related]
12. Role of radical surgery in patients with stage IV gallbladder cancer.
Kang MJ; Song Y; Jang JY; Han IW; Kim SW
HPB (Oxford); 2012 Dec; 14(12):805-11. PubMed ID: 23134181
[TBL] [Abstract][Full Text] [Related]
13. Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis.
Kim Y; Amini N; Wilson A; Margonis GA; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Cardona K; Maithel SK; Pawlik TM
Ann Surg Oncol; 2016 Sep; 23(9):2998-3008. PubMed ID: 27169772
[TBL] [Abstract][Full Text] [Related]
14. Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome.
Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
J Surg Oncol; 2018 Dec; 118(7):1096-1104. PubMed ID: 30261105
[TBL] [Abstract][Full Text] [Related]
15. Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium.
Lopez-Aguiar AG; Ethun CG; McInnis MR; Pawlik TM; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick BA; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal EW; Hatzaras I; Shenoy R; Cardona K; Maithel SK
J Surg Oncol; 2018 Jun; 117(8):1638-1647. PubMed ID: 29761515
[TBL] [Abstract][Full Text] [Related]
16. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
17. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
[TBL] [Abstract][Full Text] [Related]
18. Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer.
Lum MM; Belnap TW; Frandsen J; Brown AP; Sause WT; Soisson AP; Dodson MK; Werner T; Gaffney DK
Am J Clin Oncol; 2015 Jun; 38(3):283-8. PubMed ID: 23774072
[TBL] [Abstract][Full Text] [Related]
19. Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries.
Vinuela E; Vega EA; Yamashita S; Sanhueza M; Mege R; Cavada G; Aloia TA; Chun YS; Lee JE; Vauthey JN; Conrad C
Ann Surg Oncol; 2017 Aug; 24(8):2334-2343. PubMed ID: 28417239
[TBL] [Abstract][Full Text] [Related]
20. Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications.
Chaudhari VA; Ostwal V; Patkar S; Sahu A; Toshniwal A; Ramaswamy A; Shetty NS; Shrikhande SV; Goel M
HPB (Oxford); 2018 Sep; 20(9):841-847. PubMed ID: 29706425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
